Intuitive Surgical Inc.
ISRG | NASDAQ
$443.70
+$11.69 (+2.71%)
Nov 2, 2026, 1:38 PM ET · Market open
Company Profile
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Key Executives
| Name | Position |
|---|---|
| David J. Rosa | Chief Executive Officer & Director |
| Milind Wagle | Chief Information Officer |
| Christopher R. Carlson | Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures |
| Daniel Connally | Vice President & Head of Investor Relations |
| Fredrik Widman | Vice President, Principal Accounting Officer & Corporate Controller |
| Gary Loeb | Executive Vice President and Chief Legal & Compliance Officer |
| Gary S. Guthart | Executive Chair |
| Henry L. Charlton | Senior VP of Global Business Operations |
| Jamie E. Samath | Executive VP, CFO & Enterprise Technology Leader |
| Mark Brosius | Chief Manufacturing and Supply Chain Officer |
Intuitive Surgical Inc.
| Country | United States |
| IPO Date | Jun 16, 2000 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 17,021 |
| CEO | David J. Rosa |
Contact Details
1020 Kifer Road Sunnyvale,
California 94086-5304 United States
Stock Details
| Ticker Symbol | ISRG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001035267 |
| CUSIP Number | 46120E602 |
| ISIN Number | US46120E6023 |
| SIC Code | 3842 |
Recent News
- 1 day ago / fool.comIntuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
- 4 days ago / zacks.comISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
- 6 days ago / zacks.comIs It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
- 7 days ago / zacks.comIntuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why
- 7 days ago / zacks.comEarnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy?
- 7 days ago / zacks.comIntuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
- 11 days ago / marketbeat.comIntuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
- 12 days ago / zacks.com2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG
- 12 days ago / zacks.comISRG Q3 Earnings Call Highlights Pricing and Growth Strategy
- 12 days ago / fool.comIntuitive Surgical: 3 Key Takeaways for Long-Term Investors
Add to Watchlist
Select watchlists to add or remove ISRG